Metraipolis › archive › dc_63e6f3d2de06

A disproportionality analysis of insulin glargine in the overall population and in pregnant women using the FDA adverse event reporting system (FAERS) database — Europe PMC PMID:40997126

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40997126
DOI
10.1371/journal.pone.0331489
License (as archived)
solo-consultazione
Archived
2026-11-09T18:24:41.690Z
SHA-256 of the archived text
a96ead4b6732fb3aea6f37c8baf02c6438a0aeb66cd36d8866d38dedc223444d
Stable URL of this page
https://metraipolis.com/documento/dc_63e6f3d2de06

How to cite

A disproportionality analysis of insulin glargine in the overall population and in pregnant women using the FDA adverse event reporting system (FAERS) database — Europe PMC PMID:40997126 — Europe PMC (en), https://europepmc.org/article/MED/40997126 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_63e6f3d2de06 (Metraipolis archive dc_63e6f3d2de06, sha256 a96ead4b6732fb3aea6f37c8baf02c6438a0aeb66cd36d8866d38dedc223444d)
BibTeX
@misc{dc63e6f3d2de06,
  title = {A disproportionality analysis of insulin glargine in the overall population and in pregnant women using the FDA adverse event reporting system (FAERS) database — Europe PMC PMID:40997126},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40997126},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_63e6f3d2de06; sha256 a96ead4b6732fb3aea6f37c8baf02c6438a0aeb66cd36d8866d38dedc223444d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40997126. Agents can read the archived copy with the MCP tool read_document.